Scarica l'app Stockscreener
36.17
0.71%
-0.26
Dopo l'orario di chiusura:
34.68
-1.49
-4.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$36.43
Aprire:
$36.59
Volume 24 ore:
76,772
Relative Volume:
1.54
Capitalizzazione di mercato:
$437.21M
Reddito:
$9.71M
Utile/perdita netta:
$-29.96M
Rapporto P/E:
-10.39
EPS:
-3.48
Flusso di cassa netto:
$-14.79M
1 W Prestazione:
-1.20%
1M Prestazione:
-3.34%
6M Prestazione:
+81.12%
1 anno Prestazione:
+31.10%
Intervallo 1D:
$34.66
$37.00
Intervallo di 1 settimana:
$34.66
$39.15
Portata 52W:
$18.35
$39.92
Xoma Royalty Corp Stock (XOMA) Company Profile
Nome
Xoma Royalty Corp
Settore
Industria
Telefono
510-204-7239
Indirizzo
2200 POWELL STREET, EMERYVILLE, CA
Confronta XOMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
36.17 | 440.36M | 9.71M | -29.96M | -14.79M | -3.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-17 | Iniziato | The Benchmark Company | Buy |
| 2024-04-29 | Iniziato | Leerink Partners | Outperform |
| 2021-09-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-06-29 | Iniziato | Aegis Capital | Buy |
| 2021-01-19 | Reiterato | H.C. Wainwright | Buy |
| 2018-01-18 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-17 | Ripresa | H.C. Wainwright | Buy |
| 2017-09-05 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2017-06-12 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-14 | Downgrade | Wedbush | Outperform → Neutral |
| 2016-03-11 | Reiterato | Wedbush | Outperform |
| 2015-07-23 | Downgrade | Jefferies | Buy → Hold |
| 2015-07-22 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | Ripresa | ROTH Capital | Buy |
| 2014-04-29 | Aggiornamento | MLV & Co | Hold → Buy |
| 2014-03-11 | Downgrade | MLV & Co | Buy → Hold |
| 2014-03-05 | Reiterato | Ladenburg Thalmann | Buy |
| 2013-10-31 | Reiterato | MLV & Co | Buy |
| 2013-05-09 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-05-14 | Iniziato | Cowen & Co | Outperform |
| 2011-03-31 | Reiterato | MLV Capital | Buy |
| 2011-03-23 | Reiterato | RBC Capital Mkts | Outperform |
| 2011-01-06 | Reiterato | Ladenburg Thalmann | Buy |
| 2011-01-04 | Reiterato | Wedbush | Outperform |
Mostra tutto
Xoma Royalty Corp Borsa (XOMA) Ultime notizie
Earnings visualization tools for XOMA Royalty Corporation2025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Is XOMA Royalty Corporation stock bottoming outJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
What insider trading reveals about XOMA Royalty Corporation stockWeekly Volume Report & Verified Stock Trade Ideas - newser.com
Top chart patterns to watch in XOMA Royalty CorporationShort Setup & Daily Oversold Stock Bounce Ideas - newser.com
Short interest data insights for XOMA Royalty CorporationWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
Is now a turning point for XOMA Royalty CorporationWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for XOMA Royalty (NASDAQ:XOMA) - MarketBeat
XOMA Co. (NASDAQ:XOMAO) Short Interest Up 66.7% in September - Defense World
XOMA Royalty (NASDAQ:XOMA) Stock Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Strategies to average down on XOMA Royalty CorporationMarket Performance Report & Fast Moving Stock Watchlists - newser.com
Why XOMA Royalty Corporation (X0M1) stock attracts HNW investorsJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
XOMA Royalty PFD Update: Going Back To My Original Sell Ratings (NASDAQ:XOMA) - Seeking Alpha
XOMA Royalty Corporation (NASDAQ:XOMA) On The Verge Of Breaking Even - simplywall.st
Is XOMA Royalty Corporation stock poised for growth2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Will XOMA Royalty Corporation(X0M) stock outperform value peersTrend Reversal & Expert Verified Stock Movement Alerts - newser.com
Will XOMA Royalty Corporation (X0M1) stock profit from automation waveJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
XOMA Royalty extends tender offer deadline for LAVA Therapeutics By Investing.com - Investing.com South Africa
XOMA Royalty extends tender offer deadline for LAVA Therapeutics - Investing.com
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - The Manila Times
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - Benzinga
75% CVR: XOMA Royalty Extends Tender Offer for LAVA, Extended to Oct. 17 - Stock Titan
Press Release: ESSA Pharma Inc. Amends Agreement With XenoTherapeutics - 富途牛牛
Press Release: XOMA Royalty Declares Quarterly Preferred Stock Dividends - 富途牛牛
Xoma announces closing of tender offer for HilleVax - MSN
What analysts say about XOMA Royalty CorporationX0M stockEx-Dividend Date Alerts & Analyze Your Portfolio Risk in Seconds - earlytimes.in
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 - Yahoo Finance
Is XOMA Royalty Corporation still worth holding after the dipJuly 2025 Analyst Calls & High Accuracy Trade Alerts - newser.com
Will XOMA Royalty Corporation (X0M1) stock hit analyst forecastsMarket Risk Summary & Entry Point Confirmation Alerts - newser.com
What makes XOMA Royalty Corporation stock attractive to growth fundsQuarterly Profit Summary & Long-Term Safe Investment Ideas - newser.com
Analyzing XOMA Royalty Corporation with multi timeframe charts2025 Institutional Moves & Fast Moving Market Watchlists - newser.com
Published on: 2025-09-29 02:44:30 - newser.com
XOMA Royalty Corporation stock momentum explained2025 Sector Review & Safe Capital Preservation Plans - newser.com
XOMA Royalty files correction to Series B preferred stock designation By Investing.com - Investing.com Nigeria
XOMA Royalty files correction to Series B preferred stock designation - Investing.com India
Why XOMA Royalty Corporation (X0M1) stock stays on buy listsJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - newser.com
XOMA Royalty Declares Quarterly Preferred Stock Dividends - MSN
Essa Pharma Agrees to Amend Terms to Be Acquired by XenoTherapeutics - 富途牛牛
Xoma CFO Burns sells $155,820 in shares after option exercise By Investing.com - Investing.com South Africa
XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference - 富途牛牛
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics24.09.25News - Ariva
Xoma Royalty Corp Azioni (XOMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Xoma Royalty Corp Azioni (XOMA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hughes Owen | Chief Executive Officer |
Sep 19 '25 |
Option Exercise |
0.00 |
35,567 |
0 |
98,268 |
| BURNS THOMAS M. | SVP, Finance & CFO |
Sep 19 '25 |
Option Exercise |
0.00 |
11,846 |
0 |
34,409 |
| BURNS THOMAS M. | SVP, Finance & CFO |
Sep 22 '25 |
Sale |
35.99 |
4,330 |
155,820 |
30,079 |
| Montano Maricel Perea | Chief Legal Officer |
Sep 19 '25 |
Option Exercise |
0.00 |
3,033 |
0 |
12,134 |
| Montano Maricel Perea | Chief Legal Officer |
Sep 10 '25 |
Option Exercise |
0.00 |
9,101 |
0 |
9,101 |
| Sitko Bradley | Chief Investment Officer |
Jun 30 '25 |
Buy |
25.39 |
2,000 |
50,780 |
7,045 |
| Hughes Owen | Chief Executive Officer |
May 19 '25 |
Option Exercise |
0.00 |
53,359 |
0 |
88,338 |
| Hughes Owen | Chief Executive Officer |
May 20 '25 |
Sale |
25.38 |
25,637 |
650,667 |
62,701 |
| BURNS THOMAS M. | SVP, Finance & CFO |
May 19 '25 |
Option Exercise |
0.00 |
17,773 |
0 |
33,045 |
| BURNS THOMAS M. | SVP, Finance & CFO |
May 20 '25 |
Sale |
25.38 |
10,482 |
266,033 |
22,563 |
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):